Please login to the form below
AACR
This page shows the latest AACR news and features for those working in and with pharma, biotech and healthcare.
BMS Foundation announces Robert A Winn Diversity in Clinical Trials Award Program
The Bristol Myers Squibb Foundation (BMSF), the National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR) have revealed a new name for its initiative to increase clinical trial ... Margaret Foti, chief executive officer
Latest news
-
AstraZeneca to present new oncology data at AACR
AstraZeneca (AZ) will present new data highlighting the capabilities of its early oncology portfolio at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, which is taking place
-
BeiGene, Novartis’s PD-1 inhibitor tislelizumab hits the mark in second- or third-line NSCLC
in non-small cell lung cancer (NSCLC) at the virtual American Association for Cancer Research (AACR) annual meeting.
-
Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
The phase 1/2 LIBRETTO-001 trial – presented at the virtual American Association for Cancer Research (AACR) annual meeting – enrolled 32 patients with 12 unique RET fusion-positive advanced cancer types,
-
AZ showcases data for next-generation PARP inhibitor AZD5305
candidate. “Our data at AACR reflect a robust early-stage pipeline, poised to deliver life-changing medicines to patients living with cancer. ... Also at AACR, Zentalis Pharmaceuticals announced early-stage data for its WEE1 inhibitor – ZN-c3 – in
-
Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
Data presented at the virtual American Association for Cancer Research (AACR) annual meeting showcased results from the CheckMate-816 study, which evaluated Opdivo (nivolumab) plus chemotherapy in patients with early-stage ... AACR presentation.
More from news
Approximately 4 fully matching, plus 18 partially matching documents found.
Latest appointments
-
F-star hires ex-BMS immuno-oncology leader
He is an active member of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
September 2020: diversity and inclusion in clinical trials round-up
According to Antoni Ribas, president of AACR, "AACR is also extremely concerned that racial and ethnic minorities continue to be underrepresented in cancer research and clinical trials, especially because the different ... Ribas says AACR has formed a
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
SEVEN STONES COLLECTIVE
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
